Lung Cancer Device Study Raises Concerns for Commercial Use Lung Cancer Device Study Raises Concerns for Commercial Use
Novocure Ltd ' s experimental device to treat a type of lung cancer helped in extending overall survival among patients in a late-stage study, but concerns around its commercial success sent shares down 34%.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
More News: Allergy | Allergy & Immunology | Cancer | Cancer & Oncology | Hematology | Lung Cancer | Study